Managed Account Advisors’s Novo Nordisk NVO Stock Holding History

Managed Account Advisors’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$290M	Buy	10,585,518 +1,721,748	+19%	+$48.4M	0.24%	111
2015 Q1	$237M	Buy	8,863,770 +1,086,032	+14%	+$25M	0.21%	133
2014 Q4	$165M	Sell	7,777,738 -59,392	-0.8%	-$1.33M	0.16%	158
2014 Q3	$187M	Sell	7,837,130 -505,438	-6%	-$11.6M	0.21%	123
2014 Q2	$193M	Sell	8,342,568 -17,880	-0.2%	-$395K	0.23%	103
2014 Q1	$191M	Buy	8,360,448 +1,092,328	+15%	+$23.3M	0.25%	99
2013 Q4	$134M	Sell	7,268,120 -673,740	-8%	-$11.7M	0.18%	132
2013 Q3	$134M	Buy	7,941,860 +1,391,500	+21%	+$23.4M	0.2%	128
2013 Q2	$102M	Buy	+6,550,360	New	+$109M	0.16%	155

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Managed Account Advisors's NVO Position: Q2 2015 in Review

Managed Account Advisors increased its Novo Nordisk (NVO) stake by 19% in Q2 2015, buying an estimated $48.4M and bringing the position to 10,585,518 shares worth $290M. The position accounts for 0.24% of the portfolio, ranked #111.

Managed Account Advisors first reported a position in NVO in Q2 2013 and has held it in 9 quarters since. 516 funds tracked by Wall St. Rank hold NVO as of Q2 2015.

Managed Account Advisors held 10,585,518 shares of Novo Nordisk worth $290M as of Q2 2015.
Managed Account Advisors bought 1,721,748 Novo Nordisk shares in Q2 2015, an estimated $48.4M.
Novo Nordisk made up 0.24% of Managed Account Advisors's portfolio in Q2 2015, its #111 holding.
Managed Account Advisors first reported a position in Novo Nordisk in Q2 2013 and has held it in 9 quarters since.
516 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.